Product · #18 of 27 · hot flashes / night sweats
Bonafide Relizen
Tablet from Bonafide, made by Bonafide / Pharmavite (Otsuka). Daily serving: 2 tablets once daily.
Last updated · Price and ratings checked Nov 19, 2026
In short: Bonafide Relizen scores 48.2/100 in our ranking (#18 of 27). It costs $1.93 a day at the regular price. Evidence: pollen extract; one small product trial (n=39) + Femal RCT; best ingredient grade C (Flower pollen extract). No NSF registry listing was confirmed.
Pros
- Has its own published product trial (1 in our library); see who funded it below.
- Evidence: pollen extract; one small product trial (n=39) + Femal RCT.
Cons
- No NSF registry listing confirmed (the brand says it is third-party tested).
- Expensive: $1.93 a day at the label dose.
- Proprietary blend: some ingredient amounts are not disclosed.
Flags
FTC noticeWatchdog complaintPrivacy lawsuit
Score breakdown
Full label: what's in it
| Ingredient (as labeled) | Per day | Evidence page |
|---|---|---|
| Purified Cytoplasmic Blend – Swedish flower pollen extract (Sérélys): Pollen + Pistil extract PI-82 and Pollen extract GC-FEM – totalsplit not disclosed | 320 mg | Flower pollen extract C |
Evidence
Our evidence score: 25/40, because: pollen extract; one small product trial (n=39) + Femal RCT.
Product-level research: General-population evidence relies on related Femal RCT (Winther 2005) and observational studies; controlled pooled data non-significant. Evidence grade for the branded product: C C.
Ingredient evidence
- Flower pollen extract C (320 mg here)
Purified flower-pollen extract (the active in Relizen) is a non-hormonal ingredient studied for occasional hot flashes and night sweats*. Only two small placebo-controlled trials exist, and pooled controlled data were not statistically significant. The Menopause Society 2023: Not recommended (Level III).
Studies
Trials of this product
-
A prospective, multicenter, randomized, double-blind placebo-controlled trial on purified and specific Cytoplasmic pollen extract for hot flashes in breast cancer survivors.
39 breast-cancer survivors took the Relizen pollen ingredient or placebo for 3 months. Hot flashes fell in the active group, but the trial was very small and mainly compared women to their own starting point.
- Who
- 39 breast-cancer survivors
- Dose
- PureCyTonin (Relizen/Sérélys ingredient)
- Duration
- 3 months
- Result
- Fewer diary hot flashes vs baseline (P=.02) in the active group; well tolerated.
- Funding
- Not stated in abstract. Funding not stated
Studies on its ingredients (2)
-
Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study.
64 women took Femal flower-pollen extract or placebo for 3 months; 54 finished. Hot flashes fell more on the pollen extract, but this is a single small study.
- Who
- 64 randomized (54 completed)
- Dose
- Femal (pollen extract) 2 tablets/day
- Duration
- 3 months
- Result
- 65% responders vs 38% placebo (P<.006); diary hot flushes 27% lower vs placebo.
- Funding
- Not stated in abstract (Femal is a Natumin Pharma product). Funding not stated
-
The efficacy of purified pollen extract for reducing vasomotor symptoms in women: a systematic review and meta-analysis.
Researchers pooled every study of the pollen extract in Relizen. Women improved over 3 months, but when compared with placebo the difference disappeared, suggesting much of the benefit may be placebo. No significant side effects were seen.
- Who
- 5 studies (1 RCT + 4 observational), 420 women
- Dose
- purified cytoplasm of pollen (PureCyTonin/Relizen)
- Duration
- 3 months
- Result
- Large improvements before-vs-after, but when only controlled studies were pooled the effect was not statistically significant – may be placebo effect.
- Funding
- Authors reported no conflicts. Independent / academic
The Menopause Society's 2023 statement is in the study library.
Price
| Regular one-time price | $58.00 (60 units, 30 days at label dose) |
|---|---|
| Cost per day | $1.93 |
| Subscription | Monthly $42; 3-month $114 ($38/mo); 6-month $198 ($33/mo) |
| Price notes | Amazon B01DTKK5ES $62.00 |
| In stock when checked | Yes |
| Checked | Nov 19, 2026 |
Ratings
Amazon: ★ 4 from 1,832 ratings on Amazon (checked Nov 19, 2026)
Brand site: no average shown, 1,852 reviews on hellobonafide.com (checked Nov 19, 2026). Brand-site reviews are moderated by the brand.
Star ratings reflect buyer satisfaction, not clinical effect.
Certifications and claims
Verified in a public registry
- No registry listing found.
Claims made by the brand
- “third-party tested” Brand claim
- “FDA-registered cGMP facility” Brand claim
- “hormone-free” Brand claim
- “soy-free” Brand claim
- “gluten-free” Brand claim
- “non-GMO” Brand claim
- “paraben-free” Brand claim
Registry check: NSF/ANSI 173 ('Bonafide','Pharmavite'): not found
Who's behind it
| Brand | Bonafide |
|---|---|
| Owner / company | Bonafide Health, LLC (Harrison, NY) – owned by Pharmavite LLC (Nature Made parent; Pharmavite is part of Otsuka). equelle.com carries a 'Pharmavite Disclosure'. |
| Founders | Not stated on the pages we read. |
| Where it's made | 'made in an FDA-registered cGMP facility' (country not stated). |
| Medical advisors named |
|
| Source | hellobonafide.com |
Flags & safety
Legal, regulatory and quality flags
- TINA.org letter (Oct 2024) urging Pharmavite to review Bonafide claims (Relizen 'life bearable', Thermella 'in just two weeks'); Pharmavite received an FTC Notice of Penalty Offenses (2023). truthinadvertising.org
- M.M. v. Bonafide Health (S.D.N.Y. 7:25-cv-08618, Oct 2025) – privacy/website-tracking class action, not product quality. courtlistener.com
- Pooled data from controlled studies of this pollen extract were not statistically significant (Acquarulo 2024 meta-analysis), so the evidence is modest. study
Ingredient safety notes
- Flower pollen extract: Non-estrogenic in preclinical work; no significant adverse effects reported. Pollen allergy theoretical.
Not verified
- “Third-party tested” claim (no public registry listing found). Unverified
Sources
Talk to a clinician first
The Menopause Society's 2023 nonhormone position statement does not recommend any dietary supplement or herbal remedy for hot flashes, because the research is limited or mixed. Hormone therapy is an option for many women, and the statement lists non-hormonal options with evidence behind them: CBT, clinical hypnosis, SSRIs/SNRIs, gabapentin, fezolinetant (Level I), oxybutynin (I–II), weight loss, stellate ganglion block (II–III).
If hot flashes, night sweats, sleep or mood are affecting your life, talk to a clinician first. If you still want to try a supplement, the rankings below show what is actually in each one, what the research found, and who is behind it. Sources: position statement (PDF) · PubMed.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.